Latest news from Datamonitor

October 13, 2008
Sales and Marketing HIV

Battle for HIV drug market share getting fiercerThe HIV market, worth $9.3 billion in 2007, is expected to grow to …

The Pharmafocus Interview: Jan Lundberg

October 10, 2008
Research and Development AstraZeneca, clinical trials, drug discover

AstraZeneca's head of global drug discovery Jan Lundberg says his younger years as a sportsman have made him a determined …

Novartis pursues pulmonary hypertension indication for Glivec

October 10, 2008
Sales and Marketing

Novartis says new data on Glivec shows it has potential to treat a life-threatening heart condition, despite failing to meet …

England’s mental health policy leading Europe, says WHO

October 10, 2008
NHS, mental health

A new report from the World Health Organisation says England's mental health care has undergone a 'transformation' in the last …

UK is example to Europe on patient information, says industry

October 9, 2008
Medical Communications patients

British pharma is free to provide necessary and sufficient information to patients about its drugs, and an example to be …

Lilly eyes oncology focus with ImClone acquisition

October 9, 2008
Sales and Marketing Cancer, MA, lilly

Lilly is to buy ImClone for $6.5 billion after outbidding Bristol-Myers Squibb for the biotech company. Lilly says the acquisition …

GlycArt’s new cancer candidate to be developed with Roche

October 9, 2008
Research and Development, Sales and Marketing GlycArt, Roche

Roche is to develop a potential cancer therapy with two business partners. Genentech, the Swiss biotech company GlycArt – wholly-owned …

Advertising start-up is UK’s ‘first virtual healthcare agency’

October 7, 2008
Medical Communications digi

A new advertising agency has been launched as the UK’s first ‘virtual’ healthcare outfit, and aims to undercut traditional agencies …

Latest news from Datamonitor

October 6, 2008
Sales and Marketing OTC

Is an Rx-to-OTC move the right prescription to protect pharma revenues and cut healthcare costs? The growing cost of developing …

GSK plans research job losses in UK

October 3, 2008
Research and Development GSK, restructure

GlaxoSmithKline is set to cut about 850 jobs in early-stage research and development at sites across the world, including the …

Emerging confidence

October 2, 2008
Research and Development, Sales and Marketing emerging markets, evidence-based medicine

 The wisdom that emerging markets are vital to the pharmaceutical and biotechnology industry’s future has become a lot more conventional …

Osteoporosis drug Aclasta approved for use in men

October 2, 2008
Sales and Marketing Novartis, aclasta, osteoporosis

Osteoporosis treatment Aclasta has been approved for an extended indication in the European Union.Novartis’ once-yearly infusion has now been given …

Long-acting Zyprexa gets green light

October 2, 2008
Sales and Marketing lilly, psych

Lilly's Zypadhera has been recommended in Europe for use in stabilising schizophrenic patients who are already receiving treatment. The European …

Spiriva partners defend drug’s safety

October 2, 2008
Sales and Marketing Boehringer, COPD, Spiriva, resp

Boehringer Ingelheim and Pfizer have released new data on Spiriva to defend the safety record of the chronic obstructive pulmonary …

Weak currency helps UK pharmaceutical industry

October 1, 2008
Manufacturing and Production, Sales and Marketing parallel trade

Pharmaceutical companies operating in the UK are experiencing reduced competition from European parallel importers, thanks to the weakness of the …

Credit crunch hits European biotech

October 1, 2008
Research and Development 2008, YIR, biotech

Europe’s biotech sector is being hit hard by the credit crunch, with small and medium-sized companies being starved of funding …

Latest news from Datamonitor

September 29, 2008
Sales and Marketing par

Is cost containment impacting pharmaceutical innovation?With the cost of healthcare provision spiraling, governments and payers across the seven major markets …

The Gateway to Local Adoption Series

Latest content